The Austin, Texas-based law office of Hissey Kientz has filed a lawsuit on behalf of a 39-year-old Austin woman who died from cardiac arrest as a result of pancreatitis. The suit claims Zyprexa was the cause.
Eli Lilly, the company that manufactures Zyprexa, settled more than 18,000 claims from patients claiming the company did not properly warn of the increased risk of diabetes associated with the drug.
This past week, two residents of Louisiana’s greater Baton Rouge area filed federal lawsuits against drugmaker Eli Lilly, saying that the company failed to warn Zyprexa patients of the risk of diabetes.
Due to a recent agreement between lawyers and a federal court, Medicare and Medicaid patients who were injured by Zyprexa will see part of their settlement money given to the federal and state agencies.
A lawsuit has been filed in Lafayette County Circuit Court alleging that Eli Lilly and Co. abused Mississippi’s Medicaid reimbursement policy in order to increase profits on the antipsychotic drug Zyprexa.
A new study authored by scientists from the FDA shows the first hard evidence of some pituitary tumors being caused by antipsychotic medications.
A study has shown that the regular use of antipsychotic medication by children and adolescents has increased dramatically over the last four years. Some experts are concerned that the long-term effects could be detrimental.
After settling a lawsuit over its defective schizophrenia drug Zyprexa last year, drugmaker Eli Lilly now faces a new round of lawsuits from up to 5,000 new patients.
A study conducted at a hospital in Connecticut shows a connection between hyperglycemia (high blood sugar) and use of antipsychotic drugs.
Following FDA criticism on the safety of Zyprexa, Eli Lilly and Co. are now facing an investigation from the attorney general's office in Florida.
The Food and Drug Administration has issued a new warning detailing a higher risk of death among older people who are taking antipsychotic drugs such as Zyprexa and Clozaril to treat dementia.
Eli Lilly & Co. has announced a settlement of $690 million, intended to cover about three quarters of the claims against its blockbuster antipsychotic drug, Zyprexa.
A new warning issued by the Food and Drug Administration has helped to heighten concerns about the connection between antidepressant drugs and increased depression and suicidal thoughts.
©2008 Einstein Law All Rights Reserved